The Investor Relations website contains information about Aquinox Pharmaceuticals, Inc business for stockholders, potential investors, and financial analysts.
http://investor.aqxpharma.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
2.1 seconds
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
9
SITE IP
206.200.251.19
LOAD TIME
2.125 sec
SCORE
6.2
Investor Relations - Aquinox Pharmaceuticals, Inc | investor.aqxpharma.com Reviews
https://investor.aqxpharma.com
The Investor Relations website contains information about Aquinox Pharmaceuticals, Inc business for stockholders, potential investors, and financial analysts.
investor.aqxpharma.com
Annual Reports - Aquinox Pharmaceuticals, Inc
http://investor.aqxpharma.com/annuals-proxies.cfm
Activate excellence. Activate innovation. Activate success. File is in Briefcase. File is in Briefcase. File is in Briefcase. File is in Briefcase. Add file to Briefcase. Contact the Audit Committee. 4:00 PM ET on 11/3/16. Delayed at least 20 minutes. To subscribe to Aquinox press releases and updates.
Corporate Governance - Aquinox Pharmaceuticals, Inc
http://investor.aqxpharma.com/corporate-governance.cfm
Activate excellence. Activate innovation. Activate success. File is in Briefcase. Code of Business Conduct and Ethics. File is in Briefcase. File is in Briefcase. File is in Briefcase. Nominating and Governance Committee Charter. File is in Briefcase. Add file to Briefcase. Contact the Audit Committee. 4:00 PM ET on 11/3/16. Delayed at least 20 minutes. To subscribe to Aquinox press releases and updates.
Events & Presentations - Aquinox Pharmaceuticals, Inc
http://investor.aqxpharma.com/events.cfm
Activate excellence. Activate innovation. Activate success. Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. Click here to see Scientific and Clinical Meetings and Conferences. Canaccord Genuity 36th Annual Growth Conference. Aquinox Pharmaceuticals Q2 2016 Conference Call. Jefferies 2016 Healthcare Conference. 2016 Annual UBS Global Healthcare Conference. Annual Meeting of Stockholders. 2016 Bloom Burton and Co. Healthcare Investor Conference.
RSS News Feeds - Aquinox Pharmaceuticals, Inc
http://investor.aqxpharma.com/rss.cfm
Activate excellence. Activate innovation. Activate success. Really Simple Syndication (RSS) is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates. How do I use RSS? To make use of RSS, you'll need an RSS reader, or aggregator. An RSS aggregator can be a stand-alone application, or a plug-in for another program you already use, such as Microsoft Outlook. Paste the URL into your reader.
Email Alert Subscription - Aquinox Pharmaceuticals, Inc
http://investor.aqxpharma.com/profile.cfm
Activate excellence. Activate innovation. Activate success. Step 1 of 3: Select Options. You may automatically receive Aquinox Pharmaceuticals, Inc financial information by email. Please enter your preferences for email notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here. Current Earnings and News. All Events and Presentations. In advance of any event. Current price: 9.44.
TOTAL PAGES IN THIS WEBSITE
20
Working at Aquinox | Aquinox Pharmaceuticals
http://aqxpharma.com/content/working-aquinox
Activate excellence. Activate innovation. Activate success. Aquinox's success depends on each and every employee performing well both individually and as part of one or more of our teams. We strongly believe that how we work together, our culture is important to activating the success of our company. Three core values define our culture:. Our employees work with commitment and diligence to ensure that our objectives are delivered on time and with top quality. What it’s like to constantly feel.
User account | Aquinox Pharmaceuticals
http://aqxpharma.com/user
Activate excellence. Activate innovation. Activate success. Enter your Aquinox Pharmaceuticals username. Enter the password that accompanies your username. What it’s like to constantly feel. Like your bladder is full" - The Globe and Mail, Tuesday, Apr. 05, 2016. August 4, 2016. Aquinox Pharmaceuticals Announces Second Quarter 2016 Financial Results. August 1, 2016. Aquinox Pharmaceuticals to Announce Second Quarter 2016 Financial Results. To subscribe to Aquinox press releases and updates.
About Us | Aquinox Pharmaceuticals
http://aqxpharma.com/content/about-us
Activate excellence. Activate innovation. Activate success. We are a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Our primary focus is anti-inflammatory product candidates targeting. SH2-containing inositol-5'-phosphatase 1, or SHIP1. Which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. Our lead product candidate, AQX-1125,. August 4, 2016.
TOTAL LINKS TO THIS WEBSITE
9
ANN INC. - Investors - Overview
160; 0.08. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. ANN INC. and Vital Voices Global Partnership Empower 50 ANNpower Fellows at Fourth Annual Leadership Forum. ANN INC. Reports First Quarter 2015 Results. Ascena Retail Group, Inc. To Acquire ANN INC. For $47 Per Share In Accretive Transaction. There are currently no events scheduled. Sign up to receive e-mail alerts whenever ANN INC. posts new information to the site. Just enter your e-mail address and click Submit. Contact the Board of.
Investor Relations | Anthera Pharmaceuticals, Inc.
Skip to main navigation. Phone: 1.510.856.5600. We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. Delayed at least 20 minutes. March 12, 2018. Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura. March 7, 2018. Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference. View all press releases. March 12, 2018. March 12, 2018. View all events and presentations.
Investor Overview | Alpha and Omega Semiconductor
Skip to main navigation. 31616;体中文. Powering a Greener Future ™. Investor Information and Tools. Alpha and Omega Semiconductor Limited, or AOS, is a designer, developer and global supplier of a broad range of power semiconductor products. AOS has developed extensive intellectual property and technical knowledge that encompasses the latest advancements in the power semiconductor industry, which enables us to introduce innovative products to address the increasingly complex power requirements of adva...
Investor Relations - A.O. Smith Corporation
Looking for a water heater? July 23, 2015. A O Smith reports record earnings on strong global sales growth; raises full year EPS guidance over 10 percent. July 1, 2015. A O Smith to hold second quarter conference call on July 23. View all financial releases ». August 13, 2015. 2015 Summer Investor Presentation. July 23, 2015 at 10:00 AM ET. Second Quarter 2015 Earnings Call. May 27, 2015. Spring 2015 Investor Presentation. View all events and presentations ». A O Smith Water Heaters: See How They're Made.
AppliedMicro - Powering Your Cloud Network - Investor Relations - Investor Relations
Applied Micro Circuits Corporation at Oppenheimer Technology, Internet and Communications Conference. 160;at 10:25 am ET. Applied Micro Circuits Corporation at Oppenheimer Technology, Internet and Communications Conference. Wednesday, August 12, 2015 . 10:25 am ET . Click here for webcast. Click here to add this event to your calendar. Applied Micro Circuits Corporation at Canaccord Genuity Growth Conference. 160;at 11:00 am ET. Applied Micro Circuits Corporation at Canaccord Genuity Growth Conference.
Investor Relations - Aquinox Pharmaceuticals, Inc
Activate excellence. Activate innovation. Activate success. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Aquinox Pharmaceutical Inc's financial performance into perspective. Aquinox Pharmaceuticals Announces Positive Results From Secondary Endpoints From Phase 2 LEADERSHIP Trial in BPS/IC and Reports Second Quarter 2015 Financial Results. View all press releases ». 8/13/15 at 3:00 PM ET.
Investor Relations | Aradigm Corporation
Skip to main navigation. Mar 29, 2018. Transfer Agent and Registrar. Communications concerning stock transfer requirements, lost certificates and change of address should be directed to:. Shareholder correspondence should be mailed to:. College Station, TX 77842-3170. Overnight correspondence should be sent to:. 211 Quality Circle, Suite 210. College Station, TX 77845. Https:/ www-us.computershare.com/investor/Contact. Mar 23, 2018. Aradigm Announces Fourth Quarter 2017 and Full Year Financial Results.
Arbutus Biopharma - Investor Relations
The Baruch S. Blumberg Institute. Surface Antigen Secretion Inhibitors. Oncology, Anti-virals and Metabolic Programs. RNAi Collaborators and Partners. HBV Collaborators and Partners. Arbutus Biopharma is a publicly-traded ( NASDAQ:TKMR. In addition to our HBV Assets. We are developing a pipeline of Oncology, Anti-viral and Metabolic Programs. That leverage our expertise in RNA interference (RNAi). Therapeutics and our Lipid Nanoparticle (LNP). View all ». Aug 7, 2015. Aug 5, 2015. View all ».
Arch Coal, Inc. | Investors: Investor Relations Home
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Arch Coal's performance into perspective. Arch Coal is listed on the New York Stock Exchange (NYSE: ACI) and maintains its corporate headquarters in St. Louis, Mo. Arch Coal, Inc. Reports Second Quarter 2015 Results. Supplemental Historical Information Regional Realization and Cost Analysis. 2014 Annual Report Narrative. Or www.amstock.com.
ARIAD Pharmaceuticals, Inc: Investor home
Our Name and Logo. Our Vision, Mission and Values. Our Vision, Mission and Values. Key to long-term value: discipline, execution and consistent communication. ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer an...
Investors — Investor Information - ARI
ARI - We Create Connections. ARI has helped us support the 9 manufacturer brands we sell which has been. Essential to our growth. Our OEM part sales are up 265%. From last year.". Mdash; Powersports Dealer. Services for the Powersports industry. Up-to-date information from all of my manufacturers is critical to my business. Working with ARI saves us more than $450 per week. In outsourcing fees while growing my parts business by 125%. Mdash; OPE Dealer. Services for the Outdoor Power Equipment industry.
SOCIAL ENGAGEMENT